Clinical trial · Observational
National Lung Cancer Registry in Men and Women Based on Diagnosis in Algeria
LuCaReAl: Lung Cancer Registry in Algeria.
NCT02725892CI-TRIAL-00057143LuCaReAlcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
National, prospective, multicentric, non-interventional registry-based study, conducted among oncologists, pulmonologists in community and university hospitals, from the public sector in Algeria. The study will collect information on the characteristics, and lung carcinomas patterns of patients whose lung cancer diagnosis was confirmed by a pathologist during the study period.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oncology & Epidemiology & Lung Cancer | Lung Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| NIS observational stud | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- lungcancer patients
- description
- Men or women diagnosed with lung cancer all types and stages confirmed over 12 months of recruitment period by a pathologist
- interventionNames
- Other: NIS observational stud
Primary outcomes (1)
- measure
- incidence of lung cancer
- timeFrame
- 12 months of recruitment period
- description
- incidence of lung cancer, all types, stages and ages combined, in men and women newly diagnosed with lung cancer in Algeria over 12 months of recruitment period
Secondary outcomes (4)
- measure
- incidence of newly diagnosed lung cancer
- timeFrame
- 12 month period
- description
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Men or women diagnosed with lung cancer all types and stages confirmed over 12 months of recruitment period by a pathologist * Aged at least18 years at diagnosis * Patients who provide their informed consent form Exclusion Criteria: * Patients who did not provide the informed consent form * Patients with a mental or psychological disorder according to their treating clinicians
References
Publications (0)
Data not yet available
No reference posted for this study.